Treatment
Umbilical Cord Blood clinical trials
We’re tracking 59 recruiting studies that include Umbilical Cord Blood, each written for real people, not researchers, below.
Recruiting studies
- NCT06147986RecruitingPhase 2
Stem cell treatment after heart attack
This trial tests if umbilical cord stem cells, given alongside standard care, can help people who have had a major heart attack (STEMI). The cells are infused into the heart artery to possibly improve heart function. You may qualify if you are between 20 and 76, had a heart attack within the last 12 hours, and received a stent, and your heart's pumping ability is moderately reduced.
TaichungAges 20–75 - NCT06908616Recruiting
Study of Low White Blood Cell Counts and Blood Types in Newborns
This trial looks at how common a harmless condition called ethnic neutropenia (low white blood cells) and a specific blood type (Duffy null) are in newborns at Kaplan Medical Center. It helps doctors understand normal blood cell differences across ethnic groups.
Rehovot, IsraelAges 1 minute–1 day - NCT07249099Enrolling by invitation
Cord blood bank follow-up study
This study follows people who have stored umbilical cord blood at the Tianjin Cord Blood Bank. It collects health information to learn more about cord blood storage and its future use.
Tianjin, Tianjin MunicipalityAges Any age - NCT07297576Recruiting
Sulforaphane to speed blood recovery after cord blood transplant
This trial tests if a natural compound called sulforaphane can help your blood cells recover faster after a cord blood transplant for high-risk blood cancers. If you qualify, you would receive this supplement along with your transplant.
TianjingAges 18 years+ - NCT06174597RecruitingEarly Phase 1
Stem cells for critical limb ischemia treatment
This trial tests whether stem cells from umbilical cord arteries can help people with severe leg pain or ulcers due to blocked arteries. It is for those who cannot have surgery or other procedures.
Nanjing, JiangsuAges 18–80 - NCT06245746RecruitingPhase 1
Exosomes for low blood counts after chemo in leukemia
This trial tests whether umbilical cord mesenchymal stem cell exosomes can help restore blood cell counts after chemotherapy in adults with acute myeloid leukemia who are in remission. It aims to reduce the risk of infection and bleeding while waiting for bone marrow recovery.
Wuhan, HubeiAges 18–60 - NCT06751199Recruiting
Stem cells combined with islet transplant for diabetes
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07373054Recruiting
Stem cell treatment for male pattern baldness
This study tests whether a treatment made from stem cells from donated umbilical cords can help regrow hair in men with male pattern baldness. You would receive injections of these cell byproducts (exosomes) into your scalp to see if it slows hair loss or promotes new growth.
Fuzhou, FujianAges 18–60 - NCT05224960RecruitingPhase 2
Stem cell treatment for worsening liver cirrhosis
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
Lanzhou, GansuAges 18–75 - NCT06727721RecruitingPhase 2
Stem cell therapy for hard-to-treat type 2 diabetes
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
ShanghaiAges 18–70 - NCT06788470RecruitingPhase 1/Phase 2
Stem cell therapy for severe lung disease in premature babies
This trial tests whether umbilical cord stem cells can help premature babies with severe bronchopulmonary dysplasia (a chronic lung disease) who still need a breathing tube after standard hormone treatment. The goal is to see if it is safe and improves their lung condition.
Hangzhou, ZhejiangAges 8 months+
Common questions
- Are there clinical trials studying Umbilical Cord Blood?
- Yes. Clin2 currently lists 59 recruiting studies that include Umbilical Cord Blood, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Umbilical Cord Blood trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Umbilical Cord Blood an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Umbilical Cord Blood or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.